Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-23

Clinical Trial Update: Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares mirabegron, tamsulosin, and solifenacin for symptoms related to ureteral stents; efficacy results are not yet available from t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)
  • Solifenacin (solifenacin)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Mansoura University | Conditions: Ureteral Stent, Stent Related Symptoms | Phase 3 | Status: UNKNOWN